FDA Warns of Pradaxa GI Bleeding Risk
The FDA issued a safety announcement regarding the blood thinner Pradaxa. Results of a new study indicate patients who took Pradaxa had a higher risk of developing gastrointestinal bleeding over patients who took warfarin, another blood thinning drug. The study also indicated Pradaxa was associated with a lower risk of clot-related strokes, bleeding in the brain, and death than warfarin.
Pradaxa can be prescribed to treat patients with irregular heartbeat, or atrial fibrillation. The drug is an anticoagulant which helps keep the blood from forming clots that can sometimes cause strokes and other serious injuries.
Lawsuits have been filed against Boehringer Ingelheim, the maker of Pradaxa, for injuries including severe internal bleeding and death. If you or a loved one has taken Pradaxa (dabigatran) and have suffered an injury as a result, contact us to talk with one of our experienced product liability/personal injury attorneys to discuss your legal options.
